Works by Serrao, Alessandra
Results: 41
Single centre experience on Acquired Haemophilia A patients: Diagnosis, clinical management and analysis of factors predictive of response and outcome.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e667, doi. 10.1111/hae.14395
- By:
- Publication type:
- Article
Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 12, p. 1177, doi. 10.1007/s40261-020-00980-w
- By:
- Publication type:
- Article
Nivolumab as a safe and effective treatment in an HIV patient with refractory Hodgkin lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Long-term response to daratumumab in a patient with advanced immunoglobulin light-chain (AL) amyloidosis with organ damage.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatment.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 3, p. 393, doi. 10.1007/s00277-014-2231-9
- By:
- Publication type:
- Article
Disappearance of fibrosis in secondary myelofibrosis after ruxolitinib treatment: new endpoint to achieve?
- Published in:
- 2014
- By:
- Publication type:
- Letter
Imatinib induces body mass changes in women with chronic myeloid leukemia.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Azacitidine as salvage therapy in elderly patients with relapsed acute myeloid leukemia after autologous transplantation.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Fasting glucose level reduction induced by imatinib in chronic myeloproliferative disease with TEL-PDGFRβ rearrangement and type 1 diabetes.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Deferasirox treatment for myelodysplastic syndromes: 'real-life' efficacy and safety in a single-institution patient population.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 9, p. 1345, doi. 10.1007/s00277-012-1481-7
- By:
- Publication type:
- Article
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2022, v. 54, n. 4, p. 625, doi. 10.1007/s11239-022-02702-9
- By:
- Publication type:
- Article
Thromboembolic events following mRNA vaccines for COVID 19: a case series.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?
- Published in:
- Journal of Thrombosis & Thrombolysis, 2021, v. 52, n. 2, p. 584, doi. 10.1007/s11239-020-02354-7
- By:
- Publication type:
- Article
Satisfaction, quality of life and therapy adherence assessment in real life patients transitioning from vitamin K antagonists to direct oral anticoagulants.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 50, n. 3, p. 718, doi. 10.1007/s11239-020-02070-2
- By:
- Publication type:
- Article
PICC-related upper deep venous thrombosis in patients with hematological malignancies. Management of anticoagulant therapy according to the platelet count.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 3, p. 426, doi. 10.1007/s11239-020-02040-8
- By:
- Publication type:
- Article
The treatment of upper extremities deep vein thrombosis related to thoracic outlet syndrome with direct oral anticoagulants.
- Published in:
- Phlebology, 2021, v. 36, n. 4, p. 329, doi. 10.1177/0268355520967519
- By:
- Publication type:
- Article
Post-filter thromboembolic prophylaxis in vena cava filter carriers.
- Published in:
- Phlebology, 2021, v. 36, n. 1, p. 79, doi. 10.1177/0268355520938580
- By:
- Publication type:
- Article
Direct oral anticoagulants for the treatment of Mondor's disease not responding to low-molecular weight heparin.
- Published in:
- Phlebology, 2020, v. 35, n. 9, p. 734, doi. 10.1177/0268355520925022
- By:
- Publication type:
- Article
Use of edoxaban for the treatment of venous thromboembolism in HIV‐infected patients.
- Published in:
- HIV Medicine, 2020, v. 21, n. 3, p. e7, doi. 10.1111/hiv.12803
- By:
- Publication type:
- Article
Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants: comparison between patients with major congenital thrombophilia versus non-thrombophilic patients.
- Published in:
- Internal & Emergency Medicine, 2022, v. 17, n. 4, p. 1081, doi. 10.1007/s11739-021-02917-3
- By:
- Publication type:
- Article
Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register.
- Published in:
- Internal & Emergency Medicine, 2022, v. 17, n. 4, p. 1013, doi. 10.1007/s11739-021-02891-w
- By:
- Publication type:
- Article
Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 5, p. 0, doi. 10.1111/bjh.12079
- By:
- Publication type:
- Article
Direct oral anticoagulants in patients with hematologic malignancies.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 589, doi. 10.1002/hon.2770
- By:
- Publication type:
- Article
Impact of exclusion criteria for the DASISION and ENESTnd trials in the front-line treatment of a 'real-life' patient population with chronic myeloid leukaemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 6, p. e217, doi. 10.1111/bjh.16114
- By:
- Publication type:
- Article
A multicenter real‐life study on anticoagulant treatment with direct oral anticoagulants in patients with Ph‐negative myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. E329, doi. 10.1002/ajh.25990
- By:
- Publication type:
- Article
Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 2, p. 105, doi. 10.1002/ajh.23879
- By:
- Publication type:
- Article
Secondary Prophylaxis of Venous Thromboembolism (VTE) with Low Dose Apixaban or Rivaroxaban: Results from a Patient Population with More than 2 Years of Median Follow-up.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2024, v. 16, n. 1, p. 1, doi. 10.4084/MJHID.2024.020
- By:
- Publication type:
- Article
Epidemiology of Carbapenem Resistant Klebsiella pneumoniae Infections in Mediterranean Countries.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2016, v. 8, p. 1, doi. 10.4084/MJHID.2016.032
- By:
- Publication type:
- Article
Low Incidence Rate of Opportunistic and Viral Infections During Imatinib Treatment in Chronic Myeloid Leukemia Patients in Early and Late Chronic Phase.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2011, v. 3, n. 1, p. 1, doi. 10.4084/MJHID.2011.021
- By:
- Publication type:
- Article
Validation of a new proposed relapse risk score (CBC-score) for acute promyelocytic leukaemia.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Outcomes of long‐term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
- Published in:
- European Journal of Clinical Investigation, 2021, v. 51, n. 1, p. 1, doi. 10.1111/eci.13356
- By:
- Publication type:
- Article
Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular response.
- Published in:
- Leukemia & Lymphoma, 2016, v. 57, n. 1, p. 99, doi. 10.3109/10428194.2015.1043548
- By:
- Publication type:
- Article
Application of comorbidity indexes at baseline could be useful to predict rates of response in patients with chronic myeloid leukemia treated with imatinib.
- Published in:
- Leukemia & Lymphoma, 2014, v. 55, n. 1, p. 204, doi. 10.3109/10428194.2013.795650
- By:
- Publication type:
- Article
Azacitidine followed by radiotherapy as effective treatment for chronic myelomonocytic leukemia with extramedullary localization.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Prognostic features of patients with myelodysplastic syndromes aged < 50 years: update of a single-institution experience.
- Published in:
- Leukemia & Lymphoma, 2012, v. 53, n. 12, p. 2439, doi. 10.3109/10428194.2012.698738
- By:
- Publication type:
- Article
Evaluation of prognostic factors for overall survival in patients with chronic myelomonocytic leukemia by different scoring systems: which is the best?
- Published in:
- Leukemia & Lymphoma, 2012, v. 53, n. 10, p. 2073, doi. 10.3109/10428194.2012.666666
- By:
- Publication type:
- Article
5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials.
- Published in:
- Leukemia & Lymphoma, 2012, v. 53, n. 8, p. 1558, doi. 10.3109/10428194.2012.660632
- By:
- Publication type:
- Article
Application of French prognostic score to patients with International Prognostic Scoring System intermediate-2 or high risk myelodysplastic syndromes treated with 5-azacitidine is able to predict overall survival and rate of response.
- Published in:
- Leukemia & Lymphoma, 2012, v. 53, n. 5, p. 985, doi. 10.3109/10428194.2011.643408
- By:
- Publication type:
- Article
Trisomy 8 in Philadelphia chromosome negative cell preceding the evolution of a Philadelphia chromosome positive clone with the same additional change during imatinib treatment: revisiting the role of genetic instability in chronic myeloid leukemia.
- Published in:
- Leukemia & Lymphoma, 2012, v. 53, n. 3, p. 497, doi. 10.3109/10428194.2011.615425
- By:
- Publication type:
- Article
Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinib.
- Published in:
- Leukemia & Lymphoma, 2011, v. 52, n. 7, p. 1372, doi. 10.3109/10428194.2011.565394
- By:
- Publication type:
- Article